Showing results (11-20 of 84) with videos related to
Sort By:
Pageof 9
Experimental Diabetes Research|October 1, 2008
Transthyretin and amyloid in the islets of Langerhans in type-2 diabetesGunilla T Westermark, Per WestermarkPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 14, 2008
Review. Reflections on amyloidosis in Papua New GuineaPer Westermark, Gunilla T WestermarkMethods in Molecular Biology (Clifton, N.J.)|June 28, 2005
Purification of amyloid protein AA subspecies from amyloid-rich human tissuesGunilla T Westermark, Per WestermarkDiabetes|June 29, 2005
Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formationJohan F Paulsson, Gunilla T WestermarkAmyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 21, 2012
AA-Amyloid is cleared by endogenous immunological mechanismsSofia N Nyström, Gunilla T WestermarkCurrent Diabetes Reports|June 3, 2005
Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?Per Westermark, Arne Andersson, Gunilla T WestermarkAnnual Review of Pathology|November 12, 2014
AA amyloidosis: pathogenesis and targeted therapyGunilla T Westermark, Marcus Fändrich, Per WestermarkPhysiological Reviews|July 12, 2011
Islet amyloid polypeptide, islet amyloid, and diabetes mellitusPer Westermark, Arne Andersson, Gunilla T WestermarkPlos One|July 8, 2009
Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal modelPer Westermark, Katarzyna Lundmark, Gunilla T WestermarkMethods in Molecular Biology (Clifton, N.J.)|June 11, 2018
Development of Mouse Monoclonal Antibodies Against Human Amyloid Fibril Proteins for Diagnostic and Research PurposesGunilla T Westermark, Elisabet Ihse, Per WestermarkPageof 9